======= BBC3 ======= == Gene Information == * **Official Symbol**: BBC3 * **Official Name**: BCL2 binding component 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27113|27113]] * **UniProt**: [[https://www.uniprot.org/uniprot/"Q96PG8|Q9BXH1"|"Q96PG8|Q9BXH1"]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BBC3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BBC3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605854|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the BCL-2 family of proteins. This family member belongs to the BH3-only pro-apoptotic subclass. The protein cooperates with direct activator proteins to induce mitochondrial outer membrane permeabilization and apoptosis. It can bind to anti-apoptotic Bcl-2 family members to induce mitochondrial dysfunction and caspase activation. Because of its pro-apoptotic role, this gene is a potential drug target for cancer therapy and for tissue injury. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. |release of cytochrome c from mitochondria| |regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |positive regulation of release of cytochrome c from mitochondria| |intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress| |positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |regulation of release of cytochrome c from mitochondria| |execution phase of apoptosis| |positive regulation of establishment of protein localization to mitochondrion| |positive regulation of intrinsic apoptotic signaling pathway| |apoptotic mitochondrial changes| |regulation of mitochondrial membrane permeability| |regulation of establishment of protein localization to mitochondrion| |ATPase binding| |regulation of membrane permeability| |activation of cysteine-type endopeptidase activity involved in apoptotic process| |positive regulation of mitochondrion organization| |positive regulation of protein localization to membrane| |mitochondrial membrane organization| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process| |intrinsic apoptotic signaling pathway| |positive regulation of cysteine-type endopeptidase activity| |regulation of intrinsic apoptotic signaling pathway| |positive regulation of endopeptidase activity| |positive regulation of apoptotic signaling pathway| |regulation of mitochondrion organization| |regulation of protein localization to membrane| |positive regulation of peptidase activity| |mitochondrial transport| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of cysteine-type endopeptidase activity| |lysosome| |response to endoplasmic reticulum stress| |apoptotic signaling pathway| |positive regulation of cellular protein localization| |positive regulation of proteolysis| |regulation of apoptotic signaling pathway| |regulation of endopeptidase activity| |mitochondrion organization| |regulation of peptidase activity| |positive regulation of establishment of protein localization| |regulation of cellular protein localization| |positive regulation of organelle organization| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |regulation of proteolysis| |regulation of establishment of protein localization| |positive regulation of hydrolase activity| |membrane organization| |regulation of cellular localization| |apoptotic process| |positive regulation of transport| |positive regulation of intracellular signal transduction| |regulation of protein localization| |programmed cell death| |cell death| |positive regulation of cellular component organization| |mitochondrion| |regulation of hydrolase activity| |regulation of organelle organization| |positive regulation of catalytic activity| |regulation of apoptotic process| |regulation of programmed cell death| |positive regulation of cellular protein metabolic process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|1.71| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.88| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.28| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13215 * **Expression level (log2 read counts)**: 1.69 {{:chemogenomics:nalm6 dist.png?nolink |}}